Analysis of PD-L1 IHC tests using NIST SRM 1934-traceable reference materials: A new paradigm for development of predictive IHC biomarkers

News > Abstract > Analysis of PD-L1 IHC tests using NIST SRM 1934-traceable reference materials: A new paradigm for development of predictive IHC biomarkers

The Latest News from BCS

April 27, 2026

Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays

January 20, 2026

Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026

January 6, 2026

International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.

Innovative products delivering essential IHC performance metrics

About Us Overview BCS History Leadership Advisors

IHC Challenges Overview

Products Platform Overview IHCalibrators® Product Menu IHControls® Product Menu

News Press Releases

Learning Center

Custom Solutions